OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 12, 2022
This article provides an overview of potential tools being explored in Germany by Health Insurance Funds to better control drug prices and healthcare spend, offering insight into which measure may be implemented.
April 11, 2022
Tackling the subjective limits of value proposition.
February 18, 2022
Assessing the road ahead for Chinese biotech.
February 09, 2022
Payers not looking to favor one product.
January 17, 2022
Forging effective partnerships with local companies is particularly important when entering Brazil’s pharma market. Sameer Kolhe reports.
December 21, 2021
New technology forces industry to increase urgency.
December 09, 2021
Potential for quality equivalent to economies of scale.
October 12, 2021
Emerging limits of one-year payer time frames.
September 14, 2021
Scientific advances are benefiting cancer patients, but it will take a pandemic-like response to ensure patients everywhere have access.
September 13, 2021
Faster launch planning leads to greater access.